Nevada committee hears bill to expand IVF coverage, shield providers and define embryos in law

Senate members and public witnesses debated Senate Bill 217 on reproductive health care and assisted reproduction in a hearing of the Nevada Senate Committee on Health and Human Services, which included testimony both for and against requiring insurance coverage for infertility treatments and for statutory protections for clinics and embryos.

The bill, presented by Senate Majority Leader Nicole Cannizzaro, would require certain health insurers and public plans that cover more than 100 people to include diagnosis and treatment for infertility and fertility preservation, create a special enrollment period for people determined to be pregnant, and add legal protections for providers and others who store or transport embryos. It also states that “a fertilized egg or human embryo that exists before implantation into the uterus of a human body is not considered a human being for any purpose under Nevada law.”

Supporters told the committee that infertility affects many Nevadans and that high out‑of‑pocket costs put treatments out of reach. Amanda Klein, founder of Nevada Fertility Advocates, described her family’s multi‑year, multi‑provider path to parenthood and said: “This is what it took to bring our beautiful daughter into the world today.” Several clinicians and patient advocates testified that IVF and related services are medical care used by cancer patients, same‑sex couples, military families and others, and urged the committee to adopt the bill to preserve access.

Proponents also cited estimates discussed during testimony that spreading mandated coverage across a health plan’s membership would increase premiums by modest amounts; sponsor testimony referenced actuarial work that projected a per‑member‑per‑month cost of less than $1 for some plans. Physicians at the hearing described other medical indications for assisted reproduction and urged protections so clinics would not stop offering services.

Opponents raised three recurring objections. Several witnesses and organizations said the bill’s section declaring pre‑implantation embryos not to be legal persons is inappropriate or inconsistent with certain scientific or moral views. Melissa Clement of Nevada Right to Life told the committee: “SB 217 explicitly states that fertilized eggs and embryos before implantation are not legally considered persons.” Others pointed to the Alabama Supreme Court decision that found frozen embryos could be treated as children under that state’s wrongful‑death law and warned that legal definitions and immunity clauses could limit families’ remedies if embryos were lost due to negligence.

Industry and insurance representatives said they were willing to work with the sponsor but opposed parts of the bill as written. Shelly Caparo of the Nevada Association of Health Plans said the current draft would require large employers to provide coverage without sufficient flexibility and raised concerns about a special enrollment period for pregnancy that could conflict with federal guidance. Adam Plain of the Nevada Division of Insurance testified in a neutral posture and asked the committee to clarify language so the division would not be forced to require coverage that is not otherwise enacted: “we don't want it as a backdoor,” he said, urging statutory clarity about which policies would be required to change.

Committee members asked about cost, scope and legal protections. Senator Cannizzaro and witnesses acknowledged there would be fiscal consequences and said the sponsor was gathering actuarial and policy data and meeting with insurers to refine language. Opponents noted a fiscal estimate mentioned at the hearing that Medicaid coverage for IVF could have a large cost implication; witnesses urged caution before expanding Medicaid benefits without detailed statewide cost modeling.

The hearing closed after three hours of testimony from patient advocates, physicians, nonprofits, insurers and religious and legal opponents. No committee vote was taken at the hearing.

For now, SB217 remains a debated legislative proposal: supporters seek to expand access to fertility care and to protect clinics from legal uncertainty; opponents cite concerns about personhood, provider immunity, religious liberty and fiscal impact. Committee staff and the sponsor said they will continue discussions with stakeholders and insurers as the bill is refined before any markup or vote.